Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Bisphosphonate.
PP2A activator, Sphk1 and PKC inhibitor.
Ansamycin; bacterial DNA-dependent RNA polymera...
JAK2 inhibitor.
Polyphenolic compound present in black tea.
Non-competitive inhibitor of xanthine oxidase.<...
Alkaloid compound originally found in Corydalis...
Antipruritic.
PKD inhibitor.
Vitamin E analog, antioxidant.
Coumarin glucoside found in Aesculus, Daphne, a...
Polyphenolic compound present in black tea.
Synthetic derivative of vasicine, mucolytic.
Type A trichothecene mycotoxin produced by Fusa...
Electrophile used in 2’-hydroxyl acylation of...
Mycotoxin produced by Aspergillus; actin polyme...
BHA derivative, antioxidative food and cosmetic...
Fermentation impurity
Neuroprotective flavonoid
Sulfonylurea; ATP-sensitive K+ channel blocker....